For sponsors and CROs, building a complete view of the patient has often required piecing together data from multiple, disconnected sources. Patient Intelligence brings those insights together.
A real-time dashboard provides visibility into the PI and study sites alert activity, helping sponsors, CROs, and sites understand engagement, referral progression, and site-level performance.
See the guideline-recommended treatment landscape for a given disease. Teams can check whether a proposed protocol reflects how patients are actually recommended to be treated today, by biomarker, therapy line, and region.
Understand what happens to patients in the real world, from diagnosis through treatment decisions, line-of-therapy progression, and transitions in care. Patient Journey draws on de-identified US real-world data, including clinical notes, to surface detail often absent from structured claims or EHR data alone.
Built into Sitetrove and mapped to investigator and site records, this capability pinpoints countries and sites with higher volumes of clinically relevant patients. It also identifies US physicians near investigators who have access to the right patients for referrals.
A dedicated dashboard that feeds into trial design, country and site selection, and recruitment planning, for one consistent view.
Connects patients to the providers treating them and the sites that can reach them, including physicians with patient access, but no trial experience.
Claims, EHR, lab, prescription and clinical note data combined into a more complete patient record across therapeutic areas.
Guideline-recommended treatment shown alongside real-world practice, to spot underserved patients and recruitment challenges earlier.
Disease-specific language models extract staging, histology, biomarkers and treatment rationale from 3B+ clinical notes to identify the right trial fit.
De-identified data with clear source visibility, and documented AI outputs so teams can see where every insight comes from.
| Capability | Trialtrove / Sitetrove | With Patient Intelligence |
|---|---|---|
| Clinical trial intelligence | ||
| Site and investigator intelligence | ||
| Global patient population and epidemiology | ||
| Standard of care by biomarker and line of therapy | ||
| Real-world patient journeys and treatment patterns | ||
| Clinical note insights (staging, histology, biomarkers) | ||
| Patient access and proximity mapped to sites |
